| 000 | 01713 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250518031720.0 | ||
| 264 | 0 | _c20200127 | |
| 008 | 202001s 0 0 eng d | ||
| 022 | _a1098-2299 | ||
| 024 | 7 |
_a10.1002/ddr.21534 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aZang, Yan-Qing | |
| 245 | 0 | 0 |
_aGlycitein induces reactive oxygen species-dependent apoptosis and G0/G1 cell cycle arrest through the MAPK/STAT3/NF-κB pathway in human gastric cancer cells. _h[electronic resource] |
| 260 |
_bDrug development research _c08 2019 |
||
| 300 |
_a573-584 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAcetylcysteine _xpharmacology |
| 650 | 0 | 4 |
_aAntineoplastic Agents, Phytogenic _xpharmacology |
| 650 | 0 | 4 | _aCell Cycle Checkpoints |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
| 650 | 0 | 4 |
_aCell Survival _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIsoflavones _xpharmacology |
| 650 | 0 | 4 |
_aMAP Kinase Signaling System _xdrug effects |
| 650 | 0 | 4 |
_aMembrane Potential, Mitochondrial _xdrug effects |
| 650 | 0 | 4 |
_aNF-kappa B _xmetabolism |
| 650 | 0 | 4 |
_aReactive Oxygen Species _xmetabolism |
| 650 | 0 | 4 |
_aSTAT3 Transcription Factor _xmetabolism |
| 650 | 0 | 4 |
_aStomach Neoplasms _xdrug therapy |
| 700 | 1 | _aFeng, Yan-Yu | |
| 700 | 1 | _aLuo, Ying-Hua | |
| 700 | 1 | _aZhai, Yu-Qing | |
| 700 | 1 | _aJu, Xue-Ying | |
| 700 | 1 | _aFeng, Yu-Chao | |
| 700 | 1 | _aWang, Jia-Ru | |
| 700 | 1 | _aYu, Chang-Qing | |
| 700 | 1 | _aJin, Cheng-Hao | |
| 773 | 0 |
_tDrug development research _gvol. 80 _gno. 5 _gp. 573-584 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/ddr.21534 _zAvailable from publisher's website |
| 999 |
_c29521524 _d29521524 |
||